DoseWatch automatically detects outliers in dosing data and provides insight into their root causes, while easily documenting these anomalies for review.
Using the picture archiving and communication system (PACS) and your medical devices, DoseWatch captures, tracks, and reports radiation and contrast dose across modalities and manufacturers. The following modalities are currently supported on DoseWatch:
- CT systems
- Contrast injection systems1
- Interventional Radiology (IR) systems
- Cardio-Vascular (CV) systems
- Mammography systems
- Radiography systems
- Surgical/mobile C-arms
- Nuclear Medicine and Molecular Imaging systems2
Get dose notifications early and often to identify outliers in patient dose data
Improve workflow through access to patient dose history and integrated EMRs
Promote compliance with national dose reference level (DRLs)
Optimize patient experience
Get high-quality images at the lowest possible radiation dose
Drive better-informed, patient-centered care
4D Skin Dose Map3DoseWatch 3.1 provides an interactive tool to support the post-procedure review conducted by the interventional imaging physician or medical physicist as they perform their comprehensive assessment of skin injury risk.
Organ dose dosimetry technology from Duke University3This module estimates organ dosages based on licensed dosimetry technology developed by Duke University. Using the XCAT phantom library of patient models, it gives an absorbed dose estimation based on Duke University’s algorithm.
Dose to FetusDoseWatch 3.1 allows clinicians to take a closer look at the impact of radiation on pregnant patients with the new Dose to Fetus feature. This feature simplifies and standardizes estimates of fetal radiation exposure by automatically incorporating factors like the mother’s measurements and fetal depth.
Dr. Doug M. Hansell, Chief Medical Office of Americas, GE Healthcare
Jean Marc Pinon, Imaging manager, Creil Hospital
Jean Patrick Lajonchere, CEO, Paris St Joseph Hospital
Robert Gould, Professor and Vice Chair of Radiology for Technology and Capital Projects, University of California San Francisco
2 Tracking for single-injection procedures only and single DICOM studies.
3This feature is available in DoseWatch 3.1 and higher versions.